![Bart van Rhijn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bart van Rhijn
Director of Finance/CFO at NANOBIOTIX
Net worth: - $ as of 2024-06-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Enno Spillner | M | 55 | 10 years | |
Laurent Lévy | M | 53 | 21 years | |
Anne-Marie Graffin | F | 63 | 10 years | |
Gary Phillips | M | 58 | 3 years | |
Louis Kayitalire | M | 66 | 1 years | |
Alain Herrera | M | 74 | 13 years | |
Patrick Tricoli | M | - | 10 years | |
Anne-Juliette Hermant | F | 51 | 5 years | |
Brandon Owens | M | - | - | |
Margaret Galluzzi | F | - | 5 years | |
Mariam Hamze | F | 41 |
Galderma International SAS
![]() Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | 6 years |
Craig West | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Philippe Mauberna | M | 59 | 8 years | |
Raffaele Baffa | M | 65 |
Servier Pharmaceuticals LLC
![]() Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company, based in Boston, MA, was founded in 1954. Servier Pharmaceuticals is committed to innovation and improving the lives of patients, their families, and caregivers. The company invests in research and development to address the unmet needs of patients, particularly in the areas of oncology, cardiovascular diseases, cancers, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. The company offers financial assistance to support patients, advocacy groups, and healthcare professionals. The company strives for transparency in clinical trials and research and development. Servier Pharmaceuticals aims to create a brighter future for all by providing life-saving treatments to a greater number of patients. The company actively seeks alliances, acquisitions, licensing deals, and partnerships to accelerate access to therapies. David K. Lee has been the CEO of the company since 2018. | 2 years |
Leonard A. Farber | M | - | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
France | 14 | 93.33% |
United States | 1 | 6.67% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bart van Rhijn
- Personal Network